Apollo endosurgery, inc. (APEN)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues

10,718

11,989

11,259

14,254

13,211

15,182

14,141

15,788

15,743

-

16,544

17,109

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

5,081

-

5,826

7,088

5,970

-

6,400

6,607

6,553

-

6,012

6,636

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant and royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

13

13

183

132

199

116

201

705

353

224

230

358

219

180

406

246

338

626

769

17

Research and development revenue under collaborative agreements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43

734

770

735

978

1,132

1,603

2,106

1,845

1,663

887

955

1,060

1,106

2,577

2,882

1,531

1,202

2,152

-

988

Revenues

-

-

-

-

-

-

-

-

-

-

-

-

14,517

15,246

15,786

17,341

16,277

66,197

61

747

783

918

1,110

1,332

1,719

2,307

2,550

2,016

1,111

1,186

1,418

1,325

2,757

3,289

1,778

1,540

2,778

769

1,005

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

5,096

5,899

5,253

9,194

4,909

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross margin

5,637

5,835

5,433

7,166

7,241

7,082

7,741

9,181

9,190

9,306

10,532

10,473

9,421

9,347

10,533

8,147

11,368

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Sales and marketing

6,330

6,735

6,495

7,803

7,697

7,753

7,344

8,489

9,245

8,078

7,978

8,580

8,274

7,907

6,832

8,473

8,321

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

3,339

3,369

3,159

3,343

3,717

3,847

3,021

3,249

3,319

3,429

2,858

3,248

4,187

4,817

3,842

2,331

2,635

8,401

858

1,101

1,050

1,469

1,049

1,083

1,156

1,145

976

1,108

1,003

1,265

1,070

872

881

1,049

774

794

752

708

975

Research and development

2,147

2,139

2,128

2,689

3,428

2,895

3,671

3,154

2,456

1,879

2,178

2,285

1,957

2,583

1,782

1,786

1,654

2,455

1,430

2,916

2,755

6,258

3,630

4,574

3,663

3,566

3,353

2,839

1,584

1,823

1,700

1,532

3,101

4,713

1,705

1,378

1,929

1,155

2,756

Amortization of intangible assets

496

504

510

528

553

1,663

1,807

1,802

1,802

1,796

1,803

1,827

1,814

1,794

1,799

1,821

1,779

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Settlement gain

0

0

0

0

5,609

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

12,312

12,747

12,292

14,363

9,786

23,928

15,843

16,694

16,822

15,182

14,817

15,940

16,232

17,101

14,255

14,411

14,389

53,850

2,288

4,018

3,806

7,728

4,679

5,657

4,819

4,711

4,329

3,948

2,588

3,088

2,771

2,405

3,983

5,762

2,479

2,172

2,682

1,863

3,732

Loss from operations

-6,675

-6,912

-6,859

-7,197

-2,545

-16,846

-8,102

-7,513

-7,632

-5,876

-4,285

-5,467

-6,811

-7,754

-3,722

-6,264

-3,021

-8,163

-2,226

-3,270

-3,022

-6,809

-3,569

-4,325

-3,100

-2,403

-1,779

-1,931

-1,476

-1,902

-1,353

-1,079

-1,225

-2,472

-700

-632

95

-1,094

-2,726

Other expenses:
Interest expense, net

1,244

1,203

1,221

669

959

1,083

1,001

1,019

960

968

1,013

1,046

1,481

11,287

1,533

2,522

2,826

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense (income), net

-2,294

1,063

-498

-908

751

-355

-620

-981

516

-

451

-282

125

-

-674

-632

-58

-

-

0

-

-

-

0

-

0

-0

0

27

-47

-47

33

-28

4

31

4

-43

-60

11

Net loss before income taxes

-10,213

-7,052

-8,578

-8,774

-2,753

-18,284

-9,723

-9,513

-8,076

-7,179

-4,847

-6,795

-8,167

-19,528

-5,929

-9,418

-5,905

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

43

144

80

0

51

69

36

28

58

136

55

63

50

184

4

100

99

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-10,256

-7,196

-8,658

-8,774

-2,804

-18,353

-9,759

-9,541

-8,134

-7,315

-4,902

-6,858

-8,217

-19,712

-5,933

-9,518

-6,004

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,315

Current dividends on convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,396

2,259

2,258

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-600

-250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

400

600

-200

1,000

-750

550

200

300

300

400

1,900

-1,500

1,800

2,000

-1,700

-1,800

1,400

Total other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

-750

550

227

252

252

433

1,871

-1,495

1,831

2,004

-1,743

-1,860

1,411

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,329

-11,777

-8,262

-28,712

-2,226

-2,670

-2,772

-6,359

-3,169

-3,725

-3,300

-1,403

-2,529

-1,381

-1,249

-1,650

-1,101

-646

645

-3,968

1,130

1,371

-1,647

-2,955

-

Other comprehensive income (loss):
Foreign currency translation

1,812

-1,078

176

919

-888

211

498

383

-386

166

-227

243

142

-148

406

814

391

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-8,444

-8,274

-8,482

-7,855

-3,692

-18,142

-9,261

-9,158

-8,520

-7,149

-5,129

-6,615

-8,075

-19,860

-5,527

-8,704

-5,613

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share, basic and diluted (USD per share)

-0.49

-0.34

-0.40

-0.40

-0.13

-0.86

-0.45

-0.53

-0.47

-0.28

-0.32

-0.64

-0.77

-20.10

-24.85

-35.30

-25.44

-148.90

-1.06

-1.80

-0.14

-0.34

-0.20

-0.23

-0.23

-0.11

-0.19

-0.10

-0.09

-

-0.10

-0.06

-

-

-

-

-

-

-

Shares used in computing net loss per share, basic and diluted (shares)

21,117

20,933

21,401

21,926

21,907

21,969

21,885

18,005

17,299

17,384

15,481

10,702

10,694

564

335

333

324

-22,339

2,100

1,482

19,715

19,689

16,155

15,865

14,511

13,504

13,428

13,419

13,401

-

11,004

10,980

-

-

-

-

-

-

-

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.07

-

0.13

0.02

-0.03

-0.05

-0.02

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.07

-

0.12

0.02

-0.03

-0.05

-0.02

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,558

-

9,009

62,943

62,677

54,945

54,730

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,748

-

9,266

65,584

62,677

54,945

54,730